Daily Reporter

Today Don't Miss

Today Don't Miss

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More






Let’s talk about cancer pain

Is pain a consequence of tumour growth or a signal that treatments are not effective? Should I ever find relief from it? Or should I tolerate it? These are some of the most frequently asked…

Read More